Finance

Lists
600976:SHA
Jianmin Pharmaceutical Group Co Ltd
CNÂ¥26.99
-0.26%
(-0.070) 1D
Oct 14, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600976...
Open
CNÂ¥26.98
High
CNÂ¥27.18
Low
CNÂ¥26.90
Mkt. cap
4.15B
Avg. vol.
1.47M
Volume
713.40K
Dividend
3.33%
Quarterly dividend
CNÂ¥0.22
Ex-dividend date
Apr 28, 2026
P/E ratio
12.96
52-wk high
CNÂ¥40.73
52-wk low
CNÂ¥24.68
EPS
CNÂ¥2.08
Shares outstanding
153.40M
No. of employees
2K
Open
CNÂ¥26.98
High
CNÂ¥27.18
Low
CNÂ¥26.90
Mkt. cap
4.15B
Avg. vol.
1.47M
Volume
713.40K
Dividend
3.33%
Quarterly dividend
CNÂ¥0.22
Ex-dividend date
Apr 28, 2026
P/E ratio
12.96
52-wk high
CNÂ¥40.73
52-wk low
CNÂ¥24.68
EPS
CNÂ¥2.08
Shares outstanding
153.40M
No. of employees
2K
News stories
From web sources and news partners
About Jianmin Pharmaceutical Group Co Ltd
CEO-
Employees2.26K
Founded1637
Headquarters-
SectorPharmaceutical industry
Websitewhjm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
747.33M
817.97M
873.07M
738.07M
Cost of goods sold
308.14M
368.28M
303.81M
301.54M
Cost of revenue
308.14M
368.28M
303.81M
301.54M
Research and development expenses
25.35M
20.36M
21.28M
19.77M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
380.38M
358.68M
466.52M
334.30M
Operating expense
397.96M
414.67M
495.06M
358.84M
Total operating expenses
706.10M
782.95M
798.87M
660.38M
Operating income
41.23M
35.03M
74.20M
77.70M
Other non operating income
1.12M
4.29M
-479.82K
-132.33K
EBT including unusual items
66.53M
85.30M
97.54M
100.94M
EBT excluding unusual items
75.14M
51.48M
85.01M
90.41M
Income tax expense
298.91K
8.69M
9.23M
10.66M
Effective tax rate
0.45%
10.18%
9.46%
10.56%
Other operating expenses
-7.77M
18.05M
7.27M
4.77M
Net income
65.11M
74.10M
87.73M
89.48M
Net profit margin
8.71%
9.06%
10.05%
12.12%
Earnings per share
-
-
-
-
Interest and investment income
35.73M
17.09M
13.91M
14.82M
Interest expense
-2.94M
-4.93M
-2.62M
-1.98M
Net interest expenses
32.79M
12.16M
11.29M
12.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
49.63M
44.41M
83.59M
91.27M
Gain or loss from assets sale
-342.53K
154.53K
-
392.72K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps